Literature DB >> 11105732

The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action.

S M Stahl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11105732     DOI： 10.4088/jcp.v61n1101

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  10 in total

Review 1.  Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.

Authors:  Bart A A Franx; Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

Review 2.  N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Authors:  David Olivares; Varun K Deshpande; Ying Shi; Debomoy K Lahiri; Nigel H Greig; Jack T Rogers; Xudong Huang
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 3.  Memory loss in Alzheimer's disease: implications for development of therapeutics.

Authors:  Carl A Gold; Andrew E Budson
Journal:  Expert Rev Neurother       Date:  2008-12       Impact factor: 4.618

4.  Acetylcholinesterase inhibitors: pharmacology and toxicology.

Authors:  Mirjana B Colović; Danijela Z Krstić; Tamara D Lazarević-Pašti; Aleksandra M Bondžić; Vesna M Vasić
Journal:  Curr Neuropharmacol       Date:  2013-05       Impact factor: 7.363

5.  In vitro and in vivo study of effects of fermented soybean product (chungkookjang) on NGF secretion ability and NGF receptor signaling pathway.

Authors:  Young-Ju Lee; Ji-Eun Kim; Moon-Hwa Kwak; Jun Go; Hong-Joo Son; Dong-Seob Kim; Dae-Youn Hwang
Journal:  Lab Anim Res       Date:  2013-06-24

6.  Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer's disease rat model.

Authors:  Wei-Ting Lin; Ran-Chou Chen; Wen-Wei Lu; Shing-Hwa Liu; Feng-Yi Yang
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

7.  A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.

Authors:  Gwang-Won Kim; Byeong-Chae Kim; Kwang Sung Park; Gwang-Woo Jeong
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

8.  Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the α7 Nicotinic Receptor and Promotes Neurotoxicity.

Authors:  Evgeny P Barykin; Alexandra I Garifulina; Elena V Kruykova; Ekaterina N Spirova; Anastasia A Anashkina; Alexei A Adzhubei; Irina V Shelukhina; Igor E Kasheverov; Vladimir A Mitkevich; Sergey A Kozin; Michael Hollmann; Victor I Tsetlin; Alexander A Makarov
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

9.  Kolaviron, isolated from Garcinia kola, inhibits acetylcholinesterase activities in the hippocampus and striatum of wistar rats.

Authors:  Omamuyovwi M Ijomone; Augustine U Obi
Journal:  Ann Neurosci       Date:  2013-04

10.  Neuroactive venom compounds obtained from Phlogiellus bundokalbo as potential leads for neurodegenerative diseases: insights on their acetylcholinesterase and beta-secretase inhibitory activities in vitro.

Authors:  Simon Miguel M Lopez; Jeremey S Aguilar; Jerene Bashia B Fernandez; Angelic Gayle J Lao; Mitzi Rain R Estrella; Mark Kevin P Devanadera; Cydee Marie V Ramones; Aaron Joseph L Villaraza; Leonardo A Guevarra; Myla R Santiago-Bautista; Librado A Santiago
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.